Estrella Immunopharma, Inc. reports

Company location: Emeryville, CA
Fiscal year end: 31 December

Estrella Immunopharma, Inc. has filed 249 SEC EDGAR filings since 19 Feb 2021

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 1-7 of 7 matching filings.

Per page

25

Current page

1

10-K/A File 001-40608

AMENDMENT NO. 1 TO FORM 10-K

Filing date: 30 Apr 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40608

ANNUAL REPORT

Filing date: 18 Mar 2026
Reporting date: 31 Dec 2025
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-KT File 001-40608

TRANSITION REPORT

Filing date: 25 Mar 2025
Reporting date: 31 Dec 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K/A File 001-40608

AMENDMENT NO. 1 TO FORM 10-K

Filing date: 28 Oct 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40608

ANNUAL REPORT

Filing date: 27 Sep 2024
Reporting date: 30 Jun 2024
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40608

FORM 10-K

Filing date: 14 Mar 2023
Reporting date: 31 Dec 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-K File 001-40608

10-K

Filing date: 29 Mar 2022
Reporting date: 31 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .